ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Trovagene Submits Investigational NDA to Initiate Phase 1b/2 PCM-075 Clinical Trial for AML
June 28, 2017Trovagene announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to conduct a Phase 1b/2 clinical trial of PCM-075, their polo-like kinase 1 (PLK1) inhibitor for the treatment of patients w
Pharma Sources Insight January 2025
